tiprankstipranks
Advertisement
Advertisement
Ascentage Pharma Showcases Promising Combination Oncology Data at AACR 2026
PremiumCompany AnnouncementsAscentage Pharma Showcases Promising Combination Oncology Data at AACR 2026
19d ago
Ascentage Pharma management to meet with Piper Sandler
Premium
The Fly
Ascentage Pharma management to meet with Piper Sandler
30d ago
Ascentage Pharma management to meet with BTIG
Premium
The Fly
Ascentage Pharma management to meet with BTIG
1M ago
Ascentage Pharma Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany AnnouncementsAscentage Pharma Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend
2M ago
Ascentage Pharma initiated with a Buy at BTIG
Premium
The Fly
Ascentage Pharma initiated with a Buy at BTIG
2M ago
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
Premium
Ratings
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
2M ago
Ascentage Pharma Enhances Board Structure, Sets Shareholder Vote on Equity Grant
PremiumCompany AnnouncementsAscentage Pharma Enhances Board Structure, Sets Shareholder Vote on Equity Grant
4M ago
Ascentage Pharma Sets Out Board Line-Up and Key Committee Roles
Premium
Company Announcements
Ascentage Pharma Sets Out Board Line-Up and Key Committee Roles
4M ago
Ascentage Pharma Advances Olverembatinib With New Liver Function Study, Offering Gradual Upside for Investors
Premium
Company Announcements
Ascentage Pharma Advances Olverembatinib With New Liver Function Study, Offering Gradual Upside for Investors
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100